Andrew M. Kaunitz

11.1k total citations · 1 hit paper
244 papers, 6.9k citations indexed

About

Andrew M. Kaunitz is a scholar working on Public Health, Environmental and Occupational Health, Obstetrics and Gynecology and Reproductive Medicine. According to data from OpenAlex, Andrew M. Kaunitz has authored 244 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Public Health, Environmental and Occupational Health, 81 papers in Obstetrics and Gynecology and 55 papers in Reproductive Medicine. Recurrent topics in Andrew M. Kaunitz's work include Reproductive Health and Contraception (78 papers), Maternal and Perinatal Health Interventions (44 papers) and Menopause: Health Impacts and Treatments (42 papers). Andrew M. Kaunitz is often cited by papers focused on Reproductive Health and Contraception (78 papers), Maternal and Perinatal Health Interventions (44 papers) and Menopause: Health Impacts and Treatments (42 papers). Andrew M. Kaunitz collaborates with scholars based in United States, Switzerland and Brazil. Andrew M. Kaunitz's co-authors include Luis Sanchez‐Ramos, JoAnn E. Manson, Isaac Delke, Francisco L. Gaudier, Philip D. Darney, James A. Simon, Michael R. McClung, Douglas S. Ross, Robert L. Wears and Donna Briones and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Andrew M. Kaunitz

229 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long?

2023 76 citations Leslie Cho, Andrew M. Kaunitz et al. Circulation profile →

Peers

Countries citing papers authored by Andrew M. Kaunitz

Since Specialization

Citations

This map shows the geographic impact of Andrew M. Kaunitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew M. Kaunitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew M. Kaunitz more than expected).

Fields of papers citing papers by Andrew M. Kaunitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew M. Kaunitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew M. Kaunitz. The network helps show where Andrew M. Kaunitz may publish in the future.

Co-authorship network of co-authors of Andrew M. Kaunitz

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew M. Kaunitz. A scholar is included among the top collaborators of Andrew M. Kaunitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew M. Kaunitz. Andrew M. Kaunitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Breast cancer incidence and mortality by metabolic syndrome and obesity: The Women’s Health Initiative 2024 ·Cancer ·Rowan T. Chlebowski, Aaron K. Aragaki, Kathy Pan, Michael S. Simon, Marian L. Neuhouser, Reina Haque, Thomas E. Rohan, Jean Wactawski‐Wende, Tonya Orchard, Joanne Mortimer, Dorothy S. Lane, Andrew M. Kaunitz, Pinkal Desai, Robert A. Wild, Ana Barac, JoAnn E. Manson	15
2	Menopausal hormone therapy and ovarian and endometrial cancers: Long-term follow-up of the Women’s Health Initiative randomized trials. 2024 ·Journal of Clinical Oncology ·Rowan T. Chlebowski, Aaron K. Aragaki, Kathy Pan, Reina Haque, Thomas E. Rohan, (unknown), Jean Wactawski‐Wende, Dorothy S. Lane, Holly R. Harris, Howard D. Strickler, Andrew M. Kaunitz, Carolyn D. Runowicz	1
3	Vaginal estrogen use in breast cancer survivors: a systematic review and meta-analysis of recurrence and mortality risks 2024 ·American Journal of Obstetrics and Gynecology ·Mechthild Beste, Andrew M. Kaunitz, (unknown), Luis Sanchez‐Ramos	7
4	Single-balloon catheter with concomitant vaginal misoprostol is the most effective strategy for labor induction: a meta-review with network meta-analysis 2023 ·American Journal of Obstetrics and Gynecology ·Luis Sanchez‐Ramos, Lifeng Lin, (unknown), (unknown), (unknown), (unknown), Andrew M. Kaunitz	5
5	Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long? breakdown → 2023 ·Circulation ·Leslie Cho, Andrew M. Kaunitz, Stephanie S. Faubion, Sharonne N. Hayes, Emily S. Lau, (unknown), Nandita S. Scott, Jan L. Shifren, Chrisandra Shufelt, Cynthia A. Stuenkel, Kathryn J. Lindley	76
6	Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results 2021 ·Contraception ·Mitchell D. Creinin, Carolyn Westhoff, Céline Bouchard, Melissa J. Chen, Jeffrey T. Jensen, Andrew M. Kaunitz, Sharon L. Achilles, Jean-Michel Foidart, David F. Archer	46
7	COVID-19 Gynecology Practice Recommendations from ACOG 2020 ·Journal watch ·Andrew M. Kaunitz	2
8	A 17β-Estradiol–Progesterone Oral Capsule for Vasomotor Symptoms in Postmenopausal Women: A Randomized Controlled Trial 2018 ·Obstetrical & Gynecological Survey ·Rogerio A. Løbo, David F. Archer, Risa Kagan, Andrew M. Kaunitz, Ginger D. Constantine, James H. Pickar, Shelli Graham, Brian Bernick, Sebastián Mirkin	2
9	Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study 2017 ·Menopause The Journal of The North American Menopause Society ·Carolyn Crandall, Kathleen M. Hovey, Chris Andrews, Rowan T. Chlebowski, Marcia L. Stefanick, Dorothy S. Lane, Jan L. Shifren, Chu Chen, Andrew M. Kaunitz, Jane A. Cauley, JoAnn E. Manson	151
10	Single abnormal value on 3-hour oral glucose tolerance test during pregnancy is associated with adverse maternal and neonatal outcomes: a systematic review and metaanalysis 2016 ·American Journal of Obstetrics and Gynecology ·(unknown), Luis Sanchez‐Ramos, (unknown), Andrew M. Kaunitz	59
11	Low-Dose Levonorgestrel and Ethinyl Estradiol Patch and Pill 2014 ·Obstetrics and Gynecology ·Andrew M. Kaunitz, David Portman, Carolyn Westhoff, David F. Archer, Daniel R. Mishell, Arkady Rubin, Marie L. Foegh	16
12	The Burden of Uterine Fibroids 2013 ·Journal watch ·Andrew M. Kaunitz	0
13	Sexual Dysfunction with Aromatase Inhibitor Therapy: An Underestimated Problem? 2013 ·Journal watch ·Andrew M. Kaunitz	0
14	Letters to the Editor 2012 ·Menopause The Journal of The North American Menopause Society ·Margery Gass, JoAnn E. Manson, Cynthia A. Stuenkel, Felicia Cosman, Francine Grodstein, V. Craig Jordan, Richard H. Karas, Andrew M. Kaunitz, Pauline M. Maki, Peter J. Schmidt, Jan L. Shifren, Wulf H. Utian	11
15	Consequences of Early Menopause 2012 ·Journal watch ·Andrew M. Kaunitz	1
16	Levonorgestrel-Releasing Intrauterine System or Medroxyprogesterone for Heavy Menstrual Bleeding 2010 ·Obstetrics and Gynecology ·Andrew M. Kaunitz, François Bissonnette, Ilza Monteiro, Eeva Lukkari‐Lax, (unknown), Jeffrey T. Jensen	107
17	Breast Cancer After Age 80: Diagnosis, Treatment, and Outcomes 2010 ·Journal watch ·Andrew M. Kaunitz	1
18	Aromatase Inhibitors and Arthralgias 2008 ·Journal watch ·Andrew M. Kaunitz	2
19	Menopausal Hormone Therapy and Ovarian Cancer Risk 2007 ·Journal watch ·Andrew M. Kaunitz	4
20	An HPV Vaccine -- At Last! 2003 ·Journal watch ·Andrew M. Kaunitz	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact